Dr. Ana Maria Lopez, MD, MPH, MACP

Media Releases

Get to know Medical Oncologist Dr. Ana Maria Lopez, who serves patients in Philadelphia, Pennsylvania.

Dr. Lopez is Professor and Vice Chair of Medical Oncology & Chief of Cancer Services at Sidney Kimmel Cancer Center – Jefferson Health in Philadelphia, Pennsylvania. She brings her expertise in breast and gynecologic cancers, integrative medicine, telehealth, and cancer disparities with her to her work at the Sidney Kimmel Cancer Center of Thomas Jefferson University.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, treat patients with medical approaches to care, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management.

The Sidney Kimmel Cancer Center is committed to person-focused, multidisciplinary cancer care where nationally renowned cancer experts provide care for patients with all types of cancers, including cancers of the lung, colon and rectum, breast, pancreas, stomach, esophagus, prostate, bladder and head and neck, as well as melanoma, leukemia, lymphoma and multiple and uveal myeloma. The Center also performs autologous and allogeneic bone marrow transplantation for selected forms of cancer.

Dr. Lopez sees herself as an ameliorist, one who seeks to make things better. Her career trajectory demonstrates this commitment to care and to making better care accessible to more people. Following undergraduate studies in Philosophy at Bryn Mawr College, she earned her medical degree from Sidney Kimmel Medical College of Thomas Jefferson University. She then trained in internal medicine and hematology-oncology, completed a Master of Public Health degree in Health Policy and Administration, and was awarded a Cancer Prevention and Etiology Fellowship (T32, NCI) at the University of Arizona and the Arizona Cancer Center.

Subsequently, she joined the faculty of the University of Arizona College of Medicine and earned tenure and the academic rank of professor. She also served as medical director of the Women’s Health Initiative, founding medical director of the Arizona Telemedicine Program, and associate dean of outreach and multicultural affairs.

In 2015, Dr. Lopez moved to University of Utah Health Sciences, where she served as a professor of medicine at the University of Utah School of Medicine, director of cancer health equity at the Huntsman Cancer Institute, and associate vice president for health equity and inclusion at University of Utah Health Sciences. 

Dr. Lopez was recruited to the Sidney Kimmel Cancer Center in 2018 where she joined the faculty of the Sidney Kimmel Medical College and is affiliated with Thomas Jefferson University Hospital, Jefferson Health New Jersey, and Jefferson Methodist Hospital.

With a commitment to excellence, Dr. Lopez is board-certified in medical oncology and hematology/oncology by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Among her professional affiliations, Dr. Lopez is President Emeritus and Master of the American College of Physicians; member of the Education Committee and of the Telemedicine Standards Committee of the American Society of Clinical Oncology; and member of the Steering Committee, Group on Women In Medicine and Science, Association of American Medical Colleges. Dr. Lopez formerly served on the Board of the National Hispanic Medical Association, and is past-Chair of the Cancer Health Disparities Committee of the American Society of Clinical Oncology.

Recognized for her expertise in cancer prevention and telemedicine, Dr. Lopez has approximately 100 peer-reviewed journal articles and multiple book chapters. She has dedicated her career to addressing health inequities through community-based participatory research and through clinical trials that assess telecommunications technology to facilitate access to clinical care and education. She served as a member of Patient-Centered Outcomes Research Institute (PCORI) Advisory Panel, Healthcare Delivery and Disparities Research from August 2016 to August 2019.

Recommended Articles

• Breast Cancer Death Rate Has Dropped Dramatically in the US

  The results from a 2015 breast cancer study are in, and the news is great!The study shows there is a 39% lower death rate in the US from breast cancer. And that there has been a steady decline of such deaths since 1989. The reduction in breast cancer-related deaths is reported to be the result of...

• Anyone Can Help Breast Cancer Researchers: Here's How

  After surviving cancer, many survivors keep on fighting by taking on the roles of patient advocates. An advocate is an individual who defends or supports a cause. In the cancer society, a patient advocate is an individual who supports a cause relating to cancer by increasing awareness of the disease...

• What Are Night Sweats: Get the Facts

  What are night sweats?Night sweats are also called as nocturnal hyperhidrosis, which means excessive sweating during the night. Night sweats are episodes of continuous sweating at night even when the environmental temperature is very cold. Some people may sweat so extensively that they might find...

• New Screening Method Can Detect Tumor-Derived DNA in Women with Early Ovarian Cancer

  Diagnostic issues have plagued ovarian cancer treatment efforts. Physical symptoms of ovarian cancer are initially vague (primarily mild common gastric and urinary problems). Surgical biopsy is its primary diagnostic focus.Scientists have relied on DNA alterations found in biopsied tumor samples to...

• How to Manage Privacy When Discussing a Breast Cancer Diagnosis

  When someone is sick, most of the time they just want rest and care from loved ones. It's great to feel supported when you're not feeling well. This is very simple when it comes to having a cold, or something as common as a migraine. When the word cancer comes into the picture, everything...

• What is Large Cell Carcinoma?

  Large cell carcinoma, is a kind of lung cancer, is classified as Non-small cell lung cancer (NSCLC), and prevails in 80-85% of people who have lung cancer. This is compared to small cell lung cancer, which affects 10-15% of people.In large cell carcinoma, there will be an abnormal growth in the size...